Vitabion

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Vitabion

Property Description
Active Ingredients Thiamine (B1), Pyridoxine (B6), Cyanocobalamin (B12)
Form Film-coated tablet; Injectable solution
Pharmacological Class Specific combined vitamin preparations
Common Use Supplementation to support nervous system health
Origin Synthetic essential micronutrients

Vitabion is a specialized pharmaceutical combination product classified as a high-concentration B-complex vitamin preparation. It is formulated to provide a targeted and robust supply of three neurotropic B vitamins, distinguishing it from general, low-dose nutritional supplements. This preparation is recognized for its focused approach to supporting vital cellular and nervous system functions.


What Type of Preparation is Vitabion?

Vitabion is formally classified within the Specific combined vitamin preparations group, featuring the high-dose triad of water-soluble B vitamins: Thiamine (Vitamin B1), Pyridoxine (Vitamin B6), and Cyanocobalamin (Vitamin B12). The combination of these three neurotropic vitamins is clinically recognized for its utility in addressing metabolic deficits.

The product is uniquely offered as both an oral preparation (film-coated tablet) and a parenteral format (injectable solution) for intramuscular administration. This dual availability provides distinct therapeutic options: the tablet allows for convenient maintenance, while the injection is typically reserved for situations requiring rapid systemic delivery.


What is the Composition and General Purpose of Vitabion?

Its core composition centers on these three essential micronutrients that drive neurological health. The pharmacological importance of this specific combination product is based on the interdependent metabolic roles of these vitamins in the body. Certain Vitabion formulations may also include auxiliary compounds such as Ferrous Gluconate and Folic Acid to further enhance complementary metabolic functions.

The general purpose is to ensure the adequate supply of these micronutrients necessary for supporting nervous metabolism and the structural integrity of the nervous system. The combination is commonly used when supplementation is required to support the body's natural processes, such as during periods of increased metabolic demand or when intake is insufficient. By providing this combination, the drug supports the proper function of nerve cells and overall neurological health.

What side effects are possible with Vitabion?

Possible Side Effects and Safety Information

The official regulatory safety profile for this high-concentration combination of Thiamine (B1), Pyridoxine (B6), and Cyanocobalamin (B12) is structured around distinguishing between infrequent general reactions and specific risks tied to the dose or duration of use.

Adverse Reactions and Frequencies

Adverse reactions are documented across several System-Organ Classes, including the Immune System, Skin and Subcutaneous Tissue, and Nervous System. General reactions such as sweating, tachycardia, and various skin reactions (e.g., pruritus and urticaria) are typically classified as Rare or Very Rare in official labeling.

Serious Adverse Reactions and Duration-Related Risks

Serious adverse reactions officially documented include Anaphylactic Shock (particularly with parenteral administration) and cardiovascular events such as Pulmonary Edema or Congestive Heart Failure, which have been reported early in B12 treatment. A key safety constraint relates to the B6 component: the development of Severe Peripheral Neuropathies is associated with the chronic administration of high doses of Pyridoxine.

Safety Considerations for Specific Populations

Specific restrictions are defined in regulatory documents. Cyanocobalamin (B12) should not be used in individuals with Leber’s disease due to the risk of severe optic atrophy. The B12 component may also mask the true diagnosis of pernicious anemia, which is a high-level restriction noted in official labeling. Furthermore, some injectable formulations are restricted for use in neonates and premature infants due to the presence of Benzyl Alcohol.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for high-concentration B-complex preparations primarily documents overdose risks related to the accumulation of Pyridoxine (Vitamin B6) and severe reactions from parenteral administration of Thiamine (Vitamin B1). Patients must only refer to officially documented guidance when addressing overdose scenarios.


Documented Manifestations and Actions

Category Officially Documented Information
Overdose Presentation Symptoms are dominated by peripheral sensory neuropathy, including numbness, tingling (paresthesia), and difficulty with ambulation (ataxia). Acute overdose from injection may present with agitation or palpitation.
Severe Outcomes Listed severe risks include permanent nerve damage from long-term B6 exposure, and the acute, life-threatening risk of anaphylactic shock specifically linked to the injectable form of Thiamine.
Mandated Action Regulatory guidance requires patients to stop taking this medication immediately upon noticing specific neurological signs like tingling or numbness. If an overdose is suspected, seek professional assistance immediately.
Management Note No specific antidote is known or applicable for B-vitamin toxicity. Management is strictly limited to symptomatic and supportive treatment following immediate discontinuation of the preparation.

Regulator-Defined Risk Context

Special consideration is officially noted for neonates, who may be susceptible to hypoxaemia, and for patients with impaired kidney function, who face an increased risk of B6 toxicity. The overall overdose profile is classified as potentially leading to serious or life-threatening outcomes depending on the route and duration of exposure.

Therapeutic Uses of Vitabion

What Vitabion Treats: Main Uses and Benefits

Vitabion is commonly used to help with symptoms related to physical discomfort and symptoms related to systemic imbalance in conditions where supplementary B vitamins (B1, B6, B12) are relevant for symptomatic relief.

The combination product is considered relevant in conditions presenting with systemic or localized discomfort, such as neuritis, neuralgia, polyneuritis, lumbago, and diabetic neuropathy. These conditions often involve episodic or fluctuating manifestations.

Symptomatic Support for Discomfort

The medication is applied across domains where additional symptomatic support is needed for managing symptoms that create noticeable physiological strain, such as sharp pain, tingling, numbness, and muscle stiffness. It is frequently used during phases when symptoms become more noticeable and may interfere with daily functioning. By offering supportive symptomatic relief, it contributes to improved comfort during these periods and assists with maintaining functional stability.


Quick Fact: Symptomatic Management for Discomfort

Vitabion is considered relevant for easing symptoms related to physical discomfort, providing support that helps ease the overall symptom burden in situations where patients experience peripheral nerve symptoms.


Regulatory References

  1. Philippines Food and Drug Administration Verification Portal Product Information Sheet

Eligibility and Restrictions for Use

Who can and cannot use Vitabion?

Eligibility for Vitabion, a high-dose B1, B6, and B12 combination, is defined by regulatory bodies through specific contraindications and use restrictions documented in official product labeling.

Eligibility Status Population/Condition Regulatory Basis
Contraindicated Patients with Hypersensitivity to any component (B1, B6, B12, Cobalt, excipients). Absolute Exclusion
Contraindicated Patients receiving Levodopa therapy alone. Drug Interaction
Contraindicated Patients with Leber’s Disease or confirmed Subacute Degeneration of the Spinal Cord. Pre-existing Condition
Not Recommended Children under 14 years of age (some high-dose formulations). Safety Not Established
Not Recommended Pregnancy and Lactation. Limited Clinical Data

Use is not recommended for the combined high-dose application during pregnancy or breastfeeding due to limited clinical experience. High doses are typically reserved for populations like adults and the elderly for whom the product’s safety profile is established for the approved uses. Patients with renal impairment may require caution, particularly with injectable formulations, due to the risk of trace aluminum accumulation.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section outlines the clinically relevant and officially documented interaction patterns for Vitabion (Thiamine/B1, Pyridoxine/B6, Cyanocobalamin/B12) components, as specified in regulatory prescribing information.


Formal Restrictions and Pharmacodynamic Antagonism

Co-administration of the Pyridoxine (B6) component is formally contraindicated with Levodopa (in formulations lacking a DOPA decarboxylase inhibitor). This is due to B6 increasing the peripheral metabolism of Levodopa, which reduces its effectiveness. This restriction is classified as a pharmacodynamic antagonism.

Several agents are documented to interfere with the function or stability of the B vitamins. Medicines such as Isoniazid, Cycloserine, and Hydralazine may increase the body's requirement for Pyridoxine by acting as antagonists. Fluorouracil is documented to antagonize Thiamine (B1) by inhibiting its necessary phosphorylation step. Additionally, Nitrous Oxide use is associated with the functional inactivation of Cyanocobalamin (B12).

Exposure-Modifying Interactions

Certain products may reduce the systemic exposure to the vitamins. Long-term use of Proton Pump Inhibitors (PPIs) and H2 Receptor Antagonists can reduce the absorption of oral Cyanocobalamin (B12) due to the reduction of gastric acid. Similarly, Metformin is formally noted to reduce the intestinal absorption of B12. Chronic, excessive consumption of alcohol is also documented to reduce the absorption and increase the excretion of Thiamine (B1).

Mechanism of Action

How Vitabion Works

Vitabion functions by supplying high concentrations of three essential neurotropic B vitamins (Thiamine, Pyridoxine, and Cyanocobalamin) that act as obligate co-factors to key metabolic enzymes, thereby influencing the metabolic pathways necessary for nervous system structure and function.


Action on Neuronal Bioenergetics and Signaling Pathways

The mechanism involves the catalytic support of enzymes like Pyruvate Dehydrogenase (B1) and Glutamic Acid Decarboxylase (B6). This interaction enhances the Krebs cycle for ATP synthesis and facilitates the creation of crucial neurotransmitters, which together influence signaling dynamics and regulate the ATP available for impulse transmission.


Mechanism in Structural Maintenance and Neural Tissue Metabolism

Cyanocobalamin (B12) is a required co-factor for Methionine Synthase, which generates S-adenosylmethionine (SAMe), a vital compound for lipid methylation and the ongoing maintenance of the myelin sheath. This action is part of a metabolic synergy, where B1 provides the energy needed for B12-driven methylation, and this synergy influences the metabolic processes required for neural tissue maintenance.

Dosage and Administration Information

How Vitabion is Used: Official Administration Guidelines

Vitabion, a combination of neurotropic B vitamins (B1, B6, B12), is administered through two official routes: oral via the film-coated tablet and parenteral via the injectable solution. The method of use is typically structured into two phases according to the patient's needs.


Administration and Dosing

The choice between the oral tablet and the intramuscular (IM) injection depends on the intensity of the required intervention. The injectable solution is specified for deep intragluteal injection.

Dosage Form Standard Adult Regimen Frequency Pattern
Film-Coated Tablet 1 to 3 tablets Once daily or divided doses
IM Injection (Initial) 1 ampoule daily Daily, until acute phase subsides
IM Injection (Maintenance) 2 to 3 ampoules Intermittent, 2–3 times per week

Procedural Rules and Constraints

The course of treatment often begins with the daily IM injection for severe needs, transitioning to the lower-frequency injection or the oral tablet for long-term maintenance. If an oral dose is missed, it should be skipped if the time for the next dose is near, and patients must avoid taking a double dose.

Specific usage constraints apply to the injectable solution. It is not recommended for pregnant or lactating women due to the presence of benzyl alcohol. Additionally, official product labels do not establish administration rules or dosing schedules for pediatric patients.

Recent Clinical Evidence

Vitabion: Recent Clinical Evidence


Evidence for Use in Peripheral Nerve Symptoms

Research has examined the combined B1 (Thiamine), B6 (Pyridoxine), and B12 (Cyanocobalamin) formulation in studies exploring how symptoms change over time in patients experiencing nerve-related discomfort, such as neuritis, neuralgia, lumbago, and polyneuritis. These studies monitored changes in outcomes related to physical discomfort, including pain, tingling, and numbness, which are patient-reported outcomes describing perceived discomfort. The evidence base includes systematic reviews and randomized controlled trials (RCTs).

The findings describe patterns observed in the studies where participants reported changes observed in symptom scores over the observation periods. This research highlights changes measured during the study period primarily over short and intermediate timeframes, generally spanning between 4 and 12 weeks. The evidence base is generally described as Moderate, reflecting a significant volume of research and existing differences in trial design and strength.

Evidence for Use in Diabetic Peripheral Neuropathy

Vitabion was evaluated in studies exploring outcomes related to systemic or functional imbalance associated with Diabetic Peripheral Neuropathy (DPN). Research focused on patients with Type 1 or Type 2 Diabetes who were experiencing nerve symptoms. Studies explored how this B-vitamin combination might influence both subjective symptoms and objective functional measures, such as nerve conduction velocity.

The research highlights changes measured during the study period for both symptoms and nerve function tests. However, findings were mixed regarding the consistency of results, particularly concerning the patterns observed in objective measures. Systematic reviews noted that the quality of many of the initial RCTs in this area was low. This evidence contributes to understanding symptom patterns in DPN, but certainty remains low regarding broad, consistent patterns in physiological measures.

Understanding Evidence Gaps and Uncertainties

The evidence base is characterized by several known limitations. Follow-up durations were limited in many interventional trials, which means that long-term outcomes are not fully established. Additionally, sample sizes were modest in some of the pivotal trials, and subgroup findings are uncertain. Overall, evidence highlights what is known about symptom patterns in the short term, but what is still uncertain relates to consistent patterns in objective nerve function, long-term outcomes, and patterns of response across all patient groups.

Key Studies & References

  1. DRP-887-02_PI_01.pdf (Product Information Sheet for Registered Therapeutic Claim)

Frequently Asked Questions (FAQ)

Common questions about Vitabion (FAQ)

Q: Why do some people refer to Vitabion as a 'nerve' medicine?

A: Official documents describe Vitabion as containing what are known as neurotropic B vitamins (B1, B6, and B12). The common purpose listed for the product is to support the overall health and function of the nervous system, which is the reason for its common association with nerve-related uses.

Q: Is it true that Vitabion might cause changes in urine color?

A: Yes, official regulatory documents for high-dose B vitamins often state that the product may cause the urine to become noticeably yellow-colored or discolored. This is a recognized change commonly associated with B-complex vitamins.

Q: How long after starting Vitabion might someone notice a general effect?

A: Studies examining patient-reported outcomes for Vitabion have typically monitored changes over short to intermediate timeframes. Research has often spanned periods between four and twelve weeks to observe how symptoms change.

Q: Is Vitabion considered appropriate for older adults?

A: According to official product information, the high-dose application of Vitabion is established for use in populations such as adults and the elderly. This use is based on the product’s safety profile for its approved indications in these age groups.

Q: What if I forget to take Vitabion for a day or two?

A: Official instructions for a single missed oral dose advise that if the time for the next dose is near, the patient should simply skip the missed dose and avoid taking a double dose. The labeling specifies that doubling up should be avoided.

Q: I've heard Vitabion can help with energy; is that listed in its official purpose?

A: The official purpose of Vitabion is stated as supporting nervous metabolism. The mechanism of action involves components that enhance the body’s Krebs cycle, which is the metabolic process responsible for generating cellular energy (ATP synthesis). This is why the product is sometimes associated with energy support.

Q: What is the list of ingredients in Vitabion besides the main active component?

A: The core active ingredients are Thiamine (B1), Pyridoxine (B6), and Cyanocobalamin (B12). Some formulations may also include auxiliary compounds like Ferrous Gluconate and Folic Acid. Additionally, the injectable form contains Benzyl Alcohol as a non-active ingredient.

Q: Are there any known food or drink items that should be avoided while using Vitabion?

A: Regulatory documents specifically note that the chronic, excessive consumption of alcohol is documented to reduce the body's absorption and increase the excretion of the Thiamine (B1) component of Vitabion.

Q: What should I know about taking Vitabion if I have kidney issues?

A: Official labeling states that patients with existing renal impairment (kidney issues) may require caution when using Vitabion. This is particularly noted for injectable formulations due to the potential risk of trace aluminum accumulation.

Q: Is Vitabion studied in children, and is it ever used for them?

A: Official product labels do not establish administration rules or dosing schedules for pediatric patients. For some high-dose formulations, use is generally not recommended for children under 14 years of age.

Q: How does the body typically process and eliminate Vitabion?

A: The B vitamins in Vitabion are classified as water-soluble. After they are utilized by the body in metabolic processes, they are primarily processed by the body and eliminated through the urine.

Q: Why might Vitabion be described differently in different country's official documents?

A: Official documents, such as the FDA Label in the US or the EMA SmPC in Europe, are created based on the specific laws and submission requirements of each country’s regulatory authority. These local rules can lead to variations in the descriptive text.

Q: Are there any known interactions between Vitabion and herbal supplements?

A: Official regulatory documents focus on known interactions with prescription medicines, over-the-counter medicines, and specific substances like alcohol. Interactions with all types of herbal supplements are not universally detailed in the official prescribing information.

Q: What is the general duration of treatment with Vitabion as typically described?

A: The typical regimen involves an initial daily injection phase until the acute need subsides, followed by a lower-frequency maintenance phase. Research studies generally monitor effects over short to intermediate timeframes, usually spanning several weeks.

Q: Can taking Vitabion make you feel drowsy or affect driving?

A: Adverse reactions are documented across the Nervous System. Regulatory documents suggest patients be aware of their response to the product, especially when engaging in activities requiring concentration.

Q: Is Vitabion commonly used alongside other treatments for the same condition?

A: Research has examined the combination formulation in studies exploring symptom change in therapeutic contexts. Official labeling does not provide specific guidance on the use of the product as an adjunctive (add-on) therapy.

Q: What is the evidence theme regarding Vitabion's use in maintaining cell health?

A: The mechanism involves the B12 component supporting the creation of a compound called S-adenosylmethionine (SAMe). SAMe is vital for the ongoing process of lipid methylation and the structural maintenance of the myelin sheath, which is critical for nerve cell structure.

Q: Does Vitabion need to be stored in a special way, like kept cold?

A: Official instructions state that the product should be stored below 25 C (77 F) in a cool, dry place and be protected from light. The product does not generally require special storage in a refrigerator or freezer ('kept cold').

Q: What is the intended action of Vitabion on the peripheral nervous system?

A: The intended action involves the B-vitamin components influencing key metabolic pathways necessary for the structure and function of the nervous system. This includes enhancing cellular energy synthesis and helping to maintain the structural integrity of nerve tissues, such as the myelin sheath.

Q: Are there specific patient groups that researchers have focused on for Vitabion studies?

A: Research studies have specifically focused on patients experiencing peripheral nerve symptoms, such as neuritis or lumbago. Studies have also been conducted examining its use in patients with nerve symptoms related to Diabetic Peripheral Neuropathy (DPN).

Q: What is the maximum time frame a person is generally advised to take Vitabion continuously?

A: Regulatory safety constraints note that the development of severe peripheral neuropathies is associated with the chronic administration of high doses of the Pyridoxine (B6) component. This information is often included to highlight the need for careful consideration of continuous, high-dose administration.

Q: If I have a mild reaction, what kind of side effects are considered non-emergency?

A: General adverse reactions that are typically classified as Rare or Very Rare include sweating, rapid heart rate (tachycardia), and various skin reactions like itching (pruritus). In contrast, serious adverse reactions like Anaphylactic Shock are classified as severe in official documents.

Q: Can someone be allergic to Vitabion even if they've used similar compounds before?

A: Vitabion is formally contraindicated for patients with hypersensitivity (allergy) to any component, including the B1, B6, B12 vitamins, Cobalt, or any of the non-active excipients. This means that an allergic reaction to any part of the product is possible regardless of previous exposure to similar compounds.

How should Vitabion be stored and disposed of?

The official regulatory documents specify strict conditions for the storage and disposal of Vitabion tablets to protect the stability of the B vitamins.

Official Storage and Handling

Requirement Condition
Temperature Store below 25 C (77 F) in a cool place.
Protection Keep in a dry place and protect from light to prevent degradation.
Packaging Keep the medicine in its original container and ensure it is tightly closed.
Child Safety Store out of the sight and reach of children.

Disposal Instructions

Expired or unused Vitabion must be disposed of according to local regulations and requirements. The medication should not be discarded into wastewater (such as down a sink or toilet) or household trash, unless instructed by an official medication take-back program.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Vitabion found in:

A-Z Index: